Marker Therapeutics
MRKR
31 hedge funds and large institutions have $5.22M invested in Marker Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
4% more capital invested
Capital invested by funds: $5.04M → $5.22M (+$178K)
3% less funds holding
Funds holding: 32 → 31 (-1)
8.11% less ownership
Funds ownership: 38.26% → 30.14% (-8.1%)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$28K |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
+$12.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.11K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.09K |
| 5 |
LPL Financial
San Diego,
California
|
+$668 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$615K |
| 2 |
AAM
AR Asset Management
West Hollywood,
California
|
-$91K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$62.6K |
| 4 |
Squarepoint
New York
|
-$53.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$23.9K |
MRKR Hedge Fund Activity: Q2 2025 in Review
31 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q2 2025, worth a combined $5.22M — up 3.5% from $5.04M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MRKR and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 7 added.
The largest buyer was Jane Street, opening a new position worth an estimated $28K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $615K sold.
- 31 institutional investors held Marker Therapeutics (MRKR) as of Q2 2025, down from 32 in Q1 2025.
- Funds reported $5.22M of Marker Therapeutics stock for Q2 2025, up 3.5% quarter-over-quarter.
- 3 funds opened new Marker Therapeutics positions in Q2 2025 and 4 closed out, a net change of -1 holder.
- The largest Marker Therapeutics buyer in Q2 2025 was Jane Street, an estimated $28K added.
- The largest Marker Therapeutics seller in Q2 2025 was Hudson Bay Capital Management, an estimated $615K sold.
Based on aggregated 13F filings for Q2 2025.